SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615219-19-000008
Filing Date
2019-03-06
Accepted
2019-03-06 16:11:11
Documents
87
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K flks2018123110-k.htm 10-K 1697191
2 EXHIBIT 21.1 flks20181231ex-211.htm EX-21.1 4508
3 EXHIBIT 23.1 flks20181231ex-231.htm EX-23.1 8799
4 EXHIBIT 31.1 flks20181231ex-311.htm EX-31.1 10968
5 EXHIBIT 31.2 flks20181231ex-312.htm EX-31.2 11012
6 EXHIBIT 32.1 flks20181231ex321.htm EX-32.1 9327
  Complete submission text file 0001615219-19-000008.txt   7673274

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT flks-20181231.xml EX-101.INS 1528132
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20181231.xsd EX-101.SCH 49482
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20181231_cal.xml EX-101.CAL 80656
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20181231_def.xml EX-101.DEF 272897
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20181231_lab.xml EX-101.LAB 712438
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20181231_pre.xml EX-101.PRE 442969
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36812 | Film No.: 19662641
SIC: 2834 Pharmaceutical Preparations